1 month ago
China Implants First Commercial Brain Chip
China has successfully implanted a new brain chip called NEO in a patient with a spinal cord injury.
This chip helps the patient move their hand using a robotic glove controlled by brain signals.
The NEO chip is different from Elon Musk's Neuralink because it uses a less invasive method and doesn't require robotic surgery.
China is the first country to approve this type of brain chip for regular use.
Another company in China, NeuCyber, is also working on a similar chip called Beinao-2, which is still being tested on animals.
The NEO chip is a big step in helping people with injuries communicate and move better.
China has implanted the first commercially approved brain-computer interface (BCI) chip, NEO, in a patient with a spinal cord injury.
The NEO chip uses a minimally invasive technique and wireless technology to control a robotic glove for hand movement.
China is the first country to approve an invasive BCI medical device for commercial use.
NeuCyber's Beinao-2 system, another invasive BCI, is undergoing large-scale animal trials and is about three years behind Neuralink's progress.
The NEO chip is intended for patients aged 18-60 with specific spinal cord injuries that occurred at least one year ago.
- Who
- Neuracle, a Shanghai-based private firm
- What
- Implantation of the NEO brain-computer interface (BCI) chip
- Where
- China
- When
- Recently completed, with approval earlier this year
- Why
- To restore hand movement in patients with spinal cord injuries
Key facts
- Chip Name
- NEO
- Company
- Neuracle
- Location
- Shanghai, China
- Approval Status
- Commercially approved in China
- Target Patients
- Aged 18-60 with specific spinal cord injuries
- Technology
- Wireless, minimally invasive extradural implantation
- Comparison
- Neuralink's N1 chip uses robotic surgery for implantation
Quotes
Li Yuan
Rotating CEO of NeuCyber, a startup linked with the Beijing-based Chinese Institute for Brain Research (CIBR)
“The benchmark for Beinao-2 is Neuralink. I have to say, (there is) about three years' lag because they have over 20 patients using it already.”
wionews.com
“We have just finished the first product and have to go through animal testing, then early-feasibility clinical trials, and then the real trials. That's maybe about two years later for the real trial.”
wionews.com
Sources
Related news
VSU Adds Four New B.Tech Programs for 2026-27
IIT Bombay Launches E-PG Diploma In Computer Science And AI
IIT Roorkee Launches Online AI Programme for Working Professionals
Andhra Student Dies After Alleged Teacher Slap, Prompting Probe
Seven AI Courses Offer Paths From Free Lessons to Credentials
IIT Delhi Opens Fourth Batch of Applied AI Certificate Programme
Damaged Lohit River Bridge Cuts Off Arunachal Border Villages
Nepal Flood Exposes Delayed Alerts and Cross-Border Warning Gaps
Chinese Workers Fight Office Ageing With Parasols And Sunscreen
UPSC Key Covers SCO, Electoral Rolls, Economy, Defence and Climate
BRICS Leaders Eye Local-Currency Trade, Not Common Currency
